Bruce G. Allen Investments LLC Increases Stock Position in Colgate-Palmolive (NYSE:CL)

Bruce G. Allen Investments LLC lifted its position in Colgate-Palmolive (NYSE:CL) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,596 shares of the company’s stock after purchasing an additional 295 shares during the quarter. Bruce G. Allen Investments LLC’s holdings in Colgate-Palmolive were worth $509,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive in the 3rd quarter valued at $64,000. True Wealth Design LLC increased its stake in Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC raised its position in Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 1.3 %

Shares of CL stock traded down $1.10 during trading hours on Friday, hitting $86.36. 3,725,691 shares of the company were exchanged, compared to its average volume of 4,246,328. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The firm has a fifty day moving average of $92.76 and a 200 day moving average of $98.15. The firm has a market cap of $70.56 billion, a PE ratio of 24.75, a PEG ratio of 3.31 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.32%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Wall Street Analyst Weigh In

CL has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday. Finally, Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and an average target price of $103.63.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.